Fuss Brands Corp. (FBDS) Jun 2024 Earnings Report

FUSS BRANDS CORP: Investment Report

Overview

Fuss Brands Corp (FBDS) is a shell company operating in the financial services sector, with a market capitalization of $954,505. The company was previously known as China Botelic Pharmaceutical Inc. and changed its name to Fuss Brands Corp. in July 2022. With no significant operations, FBDS is exploring business opportunities in the United States, including potential acquisitions. This report provides an in-depth analysis of the company's financial performance, growth prospects, and market sentiment, helping investors make informed decisions.

Core Metrics

  • Current price: $0.05 USD
  • 52-week high: $0.45
  • 52-week low: $0.02
  • Market Cap: $954,505 in billions
  • P/E Ratio: N/A
  • Earnings per Share (EPS): -$0.03
  • 50-day average: $0.040884
  • 200-day average: $0.090446
  • Analyst Recommendations: none

Financial Performance

Fuss Brands Corp's financial performance has been lackluster, with a market capitalization of less than $1 million and a significant cash burn rate. The company's total cash balance stands at $7,031, while its free cash flow and operating cash flow are -$1,714,772 and -$299,962, respectively. This highlights the need for the company to secure new business opportunities or partnerships to stabilize its financial situation.

Growth Prospects

Fuss Brands Corp's growth prospects are uncertain, given its lack of significant operations and limited financial resources. However, the company's intention to explore business opportunities in the United States could lead to new partnerships or acquisitions, potentially driving growth. Investors should closely monitor the company's progress in identifying new opportunities and its ability to execute on its strategies.

News and Updates

Recent news articles do not provide significant insights into the company's operations or performance. Most articles appear to be unrelated to the company's business, with some mentioning "FBDs" in the context of free body diagrams, foodborne diseases, or RV equipment.

Upgrades and Downgrades

There have been no recent upgrades or downgrades from analyst firms, likely due to the limited interest in the stock and the company's small market capitalization.

Summary

In conclusion, Fuss Brands Corp's investment report highlights the company's uncertain growth prospects, lackluster financial performance, and limited analyst coverage. While the company's intention to explore new business opportunities is promising, investors should exercise caution and closely monitor its progress before making any investment decisions.

Disclosures

The information on this website should not be construed as or relied upon in any manner as investment, legal, tax, or other advice. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment. Any projections, estimates, forecasts, targets, prospects and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Any charts provided here or on other content distribution outlets are for informational purposes only, and should not be relied upon when making any investment decision. Under no circumstances should any information provided on this website or social media platforms be construed as an offer soliciting the purchase or sale of any security, nor should it be construed as an offer to provide investment advisory services.